MyMD Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$3,999,950 over the previous period. Total operating expenses were $17,123,048.
Profit Margin
| 2014 | 4.42M | -3.12M | -70.64% |
|---|---|---|---|
| 2015 | 2.11M | -9.31M | -440.27% |
| 2016 | 2.96M | -3.30M | -111.57% |
| 2017 | 3.92M | -5.80M | -147.74% |
| 2018 | 1.66M | -10.84M | -651.37% |
| 2019 | 1.57M | -3.88M | -246.55% |
| 2020 | 0 | -10.67M | |
| 2021 | 0 | -29.88M | |
| 2022 | 0 | -15.11M | |
| 2023 | 0 | -3.99M |
MYMD Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 1.57M | 1.66M | 3.92M | 2.96M | 2.11M | 4.42M |
Cost of revenue | 0 | 0 | 0 | 29.45K | 74.06K | 1.53M | 1.41M | 1.08M | 950.79K | 1.17M |
Gross profit | 0 | 0 | 0 | -29.45K | 1.50M | 127.28K | 2.50M | 1.87M | 1.16M | 3.25M |
Operating exp. | ||||||||||
Research and development | 7.86M | 9.06M | 6.74M | 2.46M | 3.62M | 1.06M | 1.26M | 1.18M | 1.40M | 916.30K |
Selling and marketing | 8.48M | 0 | 0 | 22.96K | 238.03K | 1.78M | 2.04M | 2.13M | 2.54M | 1.30M |
Total operating expenses | 17.12M | 15.28M | 28.20M | 8.29M | 3.32M | 8.68M | 7.56M | 6.50M | 8.21M | 6.45M |
Operating income | -17.12M | -15.28M | -28.80M | -9.48M | -3.39M | -8.55M | -5.05M | -4.62M | -7.05M | -3.20M |
Other income (expenses), net | 13.12M | 85.42K | -1.07M | -1.19M | 15.80K | -2.29M | -752.52K | 1.32M | 100.97K | 76.95K |
Income before tax | -3.99M | -15.19M | -29.88M | -9.48M | -3.38M | -10.84M | -5.80M | -3.30M | -9.58M | -3.12M |
Income tax expense | 4.21M | -85.42K | -8.90K | 1.19M | -83.65K | -2.29M | -752.52K | 1.32M | -269.34K | 15.79K |
Net income | -3.99M | -15.11M | -29.88M | -10.67M | -3.88M | -10.84M | -5.80M | -3.30M | -9.31M | -3.12M |
Earnings per share | ||||||||||
Basic EPS | -2.59 | -11.68 | -25.6 | -90.86 | -380.79 | -23.73 | -117.39 | -116.81 | -347.78 | -126.52 |
Diluted EPS | -2.59 | -11.68 | -25.6 | -90.86 | -380.79 | -23.73 | -117.39 | -116.81 | -347.78 | -126.52 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |